Masters Speciality Pharma Announces Launch of Neuropad® in Brazil for Detection of Diabetic Foot Syndrome

Masters Speciality Pharma, a UK-headquartered pharmaceutical company specialising in the global distribution of high-quality, life-changing medicines, today announces the recent launch in Brazil of Neuropad®, a rapid and reliable screening test for diabetic foot syndrome.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...